Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nissan Motor Co., Ltd. is a Japanese multinational automotive manufacturer that has expanded its research and development into the life sciences and healthcare sectors, particularly in the field of infection control. The company has pioneered a novel antiviral technology in collaboration with Tohoku University's Faculty of Pharmaceutical Sciences, utilizing organic nitroxyl radical oxidation catalysts to inactivate pathogens such as SARS-CoV-2, fungi, and bacteria. This technology works by denaturing viral surface proteins through aerobic oxidation and is intended for application in medical textiles, air purification systems, and protective equipment. Additionally, Nissan has leveraged its global manufacturing infrastructure to produce ventilators and personal protective equipment (PPE) and develops specialized mobility solutions for the healthcare sector, including advanced ambulances. While primarily known for its automotive brands, Nissan's healthcare initiatives represent a strategic application of its materials science expertise to address public health challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nissan Motor.